You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

OXISTAT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Oxistat patents expire, and when can generic versions of Oxistat launch?

Oxistat is a drug marketed by Fougera Pharms and Ani Pharms and is included in two NDAs.

The generic ingredient in OXISTAT is oxiconazole nitrate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxiconazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oxistat

A generic version of OXISTAT was approved as oxiconazole nitrate by TARO on March 7th, 2016.

  Try a Trial

US Patents and Regulatory Information for OXISTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms OXISTAT oxiconazole nitrate CREAM;TOPICAL 019828-001 Dec 30, 1988 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ani Pharms OXISTAT oxiconazole nitrate LOTION;TOPICAL 020209-001 Sep 30, 1992 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.